Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F20%3A00012995" target="_blank" >RIV/00023736:_____/20:00012995 - isvavai.cz</a>

Result on the web

<a href="https://doi.org/10.3324/haematol.2018.212332" target="_blank" >https://doi.org/10.3324/haematol.2018.212332</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3324/haematol.2018.212332" target="_blank" >10.3324/haematol.2018.212332</a>

Result language

angličtina

Original language name

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Original language description

Iron overload due to red blood cell (RBC) transfusions is associated with morbidity and mortality in lower-risk myelodysplastic syndrome (MDS) patients. Many studies have suggested improved survival after iron chelation therapy (ICT), but valid data are limited. The aim of this study was to assess the effect of ICT on overall survival and hematologic improvement in lower-risk MDS patients in the European MDS registry.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30205 - Hematology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2020

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Haematologica

ISSN

0390-6078

e-ISSN

—

Volume of the periodical

105

Issue of the periodical within the volume

3

Country of publishing house

IT - ITALY

Number of pages

12

Pages from-to

640-651

UT code for WoS article

000518368400031

EID of the result in the Scopus database

2-s2.0-85075016771